Peripheral Vascular Devices Market Global Forecast Report by Device Type (Stents, PTA Balloon Catheters, PTA Guidewires, Atherectomy Devices, Embolic Protection Devices, Inferior Vena Cava Filters, Other), Country and Company Analysis 2024-2032
Buy NowPeripheral Vascular Devices Market Size
The global peripheral vascular devices market is expected to reach US$ 18.47 billion by 2032 up from US$ 12.10 Billion in 2023. This market is expected to grow at CAGR of 4.81% from 2024 to 2032. Because older populations are more likely to suffer peripheral artery disorders (PAD), the global market for peripheral vascular devices is anticipated to grow positively over the forecast period. Peripheral vascular problems are also highly susceptible due to the rising incidence of lifestyle diseases like obesity and diabetes. Peripheral vascular devices are in higher demand as difficult open surgeries are being replaced by less invasive endovascular procedures.
Peripheral vascular devices Market Outlooks
Peripheral vascular devices are a unique example of how medical innovation and technology may come together to address a range of circulatory system issues that impact the arteries, veins, and capillaries that are not connected to the heart or brain. Peripheral vascular disorders (PVDs) are a wide range of conditions that can cause tissue injury, decreased blood flow, and even potentially fatal consequences. The development of sophisticated tools and technologies to aid in the diagnosis, treatment, and management of these disorders is the main objective of the peripheral vascular devices sector. In the end, these developments will improve patients' quality of life, relieve symptoms, and restore blood flow. The foundation of any successful medical intervention is an accurate diagnosis.
Peripheral vascular disease diagnostic techniques have revolutionized the way doctors assess blood vessel health. These gadgets accurately identify the kind and severity of vascular disorders using cutting-edge technologies. Real-time blood flow visualization is made possible by non-invasive methods like Doppler ultrasound, which aid in the detection of vascular irregularities such stenosis and occlusion. Advanced imaging techniques that produce high-resolution images of blood arteries, such as magnetic resonance angiography (MRA) and computed tomography angiography (CTA), facilitate clinical decision-making.
| Report Features | Details |
|
Base Year |
2023 |
|
Forecast Years |
2024 - 2032 |
|
Historical Years |
2019 - 2023 |
|
Market Size in 2023 |
US$ 12.10 Billion |
|
Market Forecast in 2032 |
US$ 18.47 Billion |
|
Market Growth Rate (2024-2032) |
4.81% |
Growth Drivers of the Peripheral Vascular Devices Market
Growing Rate of Cardiovascular Illnesses
Significant lifestyle changes, smoking, and unhealthy eating habits all contribute to the development of PVDs. As people become more aware of these risk factors and the value of preventive healthcare, they are looking for early therapies to maintain their cardiovascular health. This shift in the way people seek healthcare has led to an increase in the demand for peripheral vascular devices that can identify and treat these disorders at an early stage. As a result, patient awareness and the desire to adopt healthier lives have driven a boom in the industry. Peripheral artery disease (PAD) in the lower extremities affects more than 220 million people worldwide.
The scientific study titled 'Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions' published by the American Heart Association in August 2021 found a correlation between it and an increased risk of multiple unfavorable clinical outcomes, including cardiovascular diseases like stroke and limb outcomes like amputation, in addition to coronary heart disease. Peripheral vascular devices are projected to have an increase in demand in the coming years due to the increased incidence of PAD.
Technological developments driving market expansion
Innovations in technology are driving the market for next-generation peripheral vascular devices. Global opportunities for peripheral vascular treatments have expanded as a result of device makers' strategic investments in the creation of technologically advanced products with improved efficacy, safety, and cost-effectiveness. To create novel stents such as drug-eluting stents and bioresorbable scaffolds, for example, major players in the market are concentrating on nanotechnologies and bioabsorbable materials. Compared to traditional metallic stents, these innovative product lines are producing better clinical results and lowering problems related to metal allergy. Furthermore, the development of sophisticated imaging techniques such as optical coherence tomography (OCT) has made it possible to visualize processes better and evaluate results more accurately. OCT helps doctors install devices optimally by enabling high-resolution, three-dimensional cross-sectional imaging.
North America Peripheral Vascular Devices Market
Due to a number of factors, including the rising prevalence of cardiovascular diseases, an aging population, the strong presence of industry players in the area, improved healthcare infrastructure, public awareness of available technologies among stakeholders in the healthcare industry, and a high concentration of market players in the United States, North America is predicted to dominate the market.
As per the 'Heart Disease Facts' article issued in September 2020 by the Centers for Disease Control and Prevention (CDC), heart disease stands as the primary cause of mortality in the United States. According to the same source, roughly 805,000 Americans suffer a heart attack annually. Peripheral vascular devices are predicted to grow during the forecast period because they aid in the treatment of artery blockages and narrowing, which is why there is a constant need for cardiac disease therapy as the number of heart disease-related deaths rises.
The market is expanding as a result of the growing number of partnerships, product launches, and acquisitions, especially in the US. For example, Siemens Healthineers introduced the next-generation ACUSON AcuNav Volume 4D ICE Catheter in the US in March 2022. The business claims that the AcuNav Volume ICE catheter changes the way that care is provided by treating patients who were previously unable to have structural heart surgeries.
Furthermore, Walk Vascular, LLC, a medical device firm with a minimally invasive mechanical aspiration thrombectomy system intended to remove peripheral blood clots, was acquired by Abbott in September 2021, according to an announcement made by the company. Abbott will add Walk Vascular's peripheral thrombectomy systems to its current line of endovascular products. Abbott was able to broaden the scope of its peripheral vascular services thanks to the partnership.
Peripheral Vascular Devices Company Overview
The major global peripheral vascular devices industry players include Abbott Laboratories, Boston Scientific, Becton Dickinson and Company, Cook, Cordis Corporation, Edward Lifesciences, Medtronic and Volcano Corporation.
Peripheral Vascular Devices Company news
In March 2024, the first patient has been enrolled in the "AGILITY" investigational device exemption (IDE) study, which aims to assess the safety and effectiveness of the BD Vascular Covered Stent for the treatment of peripheral arterial disease (PAD). BD is a prominent worldwide medical technology company. The Vascular Covered Stent, which is being studied, is a low-profile, self-expanding nickel oxide implant covered in polytetrafluoroethylene.
In February 2024, The FDA has designated Efemoral Vascular Scaffold System (EVSS) as a Breakthrough Device for treating de novo or restenotic lesions of the infrapopliteal arteries in patients with Chronic Limb Threatening Ischemia (CLTI). Efemoral Medical is a developer of advanced interventional bioresorbable therapies.
In March 2023, as a leader in the development of Intravascular Lithotripsy (IVL) for the treatment of severely calcified cardiovascular disease, Shockwave Medical, Inc. has announced that the Shockwave L6 Peripheral IVL Catheter is now available for purchase in the United States after receiving FDA clearance. The purpose of the Shockwave L6 catheter is to modify calcification in significant peripheral artery lesions, such the iliac and common femoral arteries, that would otherwise be challenging to treat.
Device Type: Market is divided into 7 Viewpoints
- Peripheral Vascular Stents
- Peripheral Transluminal Angioplasty (PTA) Balloon Catheters
- Peripheral Transluminal Angioplasty (PTA) Guidewires
- Atherectomy Devices
- Embolic Protection Devices
- Inferior Vena Cava Filters
- Other Device Types
Country: Market is divided into 23 Country
North America
- United States
- Canada
Europe
- France
- Germany
- Italy
- Spain
- United Kingdom
- Netherlands
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Malaysia
- Indonesia
- Israel
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
All the key players have been covered from 4 Viewpoints:
- Key Person
- Company overview
- Recent Development
- Product Portfolio
- Sales Analysis
Company Analysis
- Abbott Laboratories
- Boston Scientific Corporation
- Becton, Dickinson and Company
- Cook
- Cordis Corporation
- Edward Lifesciences
- Medtronic
- Volcano Corporation
Report Details:
| Report Features | Details |
| Base Year |
2023 |
| Historical Period |
2019 - 2023 |
| Forecast Period |
2024 - 2032 |
| Market |
US$ Billion |
| Segment Covered |
Device Type, and Countries |
| Countries Covered |
|
| Companies Covered |
|
| Customization Scope |
20% Free Customization |
| Post-Sale Analyst Support |
1 Year (52 Weeks) |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on request) |
Key Questions Answered in this Report
- How big is the Peripheral Vascular Devices industry?
- What is the Peripheral Vascular Devices industry growth rate?
- Who are the key players in Peripheral Vascular Devices industry?
- What are the factors driving the Peripheral Vascular Devices industry?
- Which Region held the largest market share in the Peripheral Vascular Devices industry?
- What segments are covered in the Peripheral Vascular Devices Market report?
Customization Services available
- Analysis of Market Size and Its Segments
- More Company Profiles (Upto 10 without any additional cost):
- Additional Countries (Other than mentioned Countries):
- Region/Country Specific Reports:
- Market Entry Strategy:
- Region-Specific Market Dynamics:
- Regional Market Share Analysis:
- Trade Analysis:
- Production Insights:
- Others Customized Requests:
For more information contact our analysts.
Need More Assistance?
- Talk to our analysts to get more precious information on the current market trends.
- Include more countries and segments and customize the report based on the final requirement.
- Get a competitive advantage in your industry by knowing the report findings and making a positive impact on your revenues and operations.
- Our analysts are always ready to provide more help and pertinent information if you need any additional assistance.
1 Introduction
2 Research Methodology
3 Executive Summary
4 Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5 Global Peripheral Vascular Devices Market
6 Market Share
6.1 By Device Type
6.2 By Countries
7 By Device Type
7.1 Peripheral Vascular Stents
7.2 Peripheral Transluminal Angioplasty (PTA) Balloon Catheters
7.3 Peripheral Transluminal Angioplasty (PTA) Guidewires
7.4 Atherectomy Devices
7.5 Embolic Protection Devices
7.6 Inferior Vena Cava Filters
7.7 Other Device Types
8 By Country
8.1 North America
8.8.1 United States
8.8.2 Canada
8.2 Europe
8.2.1 France
8.2.2 Germany
8.2.3 Italy
8.2.4 Spain
8.2.5 United Kingdom
8.2.6 Netherlands
8.3 Asia Pacific
8.3.1 China
8.3.2 Japan
8.3.3 India
8.3.4 Australia
8.3.5 South Korea
8.3.6 Malaysia
8.3.7 Indonesia
8.3.8 Israel
8.4 Latin America
8.4.1 Brazil
8.4.2 Mexico
8.4.3 Argentina
8.4.4 Colombia
8.5 Middle East & Africa
8.5.1 South Africa
8.5.2 Saudi Arabia
8.5.3 UAE
8.6 Rest of World
9 Porter’s Five Forces Analysis
9.1 Bargaining Power of Buyer
9.2 Bargaining Power of Supplier
9.3 Threat of New Entrants
9.4 Rivalry among Existing Competitors
9.5 Threat of Substitute Products
10 SWOT Analysis
10.1 Strength
10.2 Weakness
10.3 Opportunity
10.4 Threat
11 Company Analysis
11.1 Abbott Laboratories
11.1.1 Key Person
11.1.2 Company overview
11.1.3 Recent Development
11.1.4 Product Portfolio
11.1.5 Sales Analysis
11.2 Boston Scientific Corporation
11.2.1 Key Person
11.2.2 Company overview
11.2.3 Recent Development
11.2.4 Product Portfolio
11.2.5 Sales Analysis
11.3 Becton, Dickinson and Company
11.3.1 Key Person
11.3.2 Company overview
11.3.3 Recent Development
11.3.4 Product Portfolio
11.3.5 Sales Analysis
11.4 Cook
11.4.1 Key Person
11.4..2 Company overview
11.4.3 Recent Development
11.4.4 Product Portfolio
11.4.5 Sales Analysis
11.5 Cordis Corporation
11.5.1 Key Person
11.5.2 Company overview
11.5.3 Recent Development
11.5.4 Product Portfolio
11.5.5 Sales Analysis
11.6 Edward Lifesciences
11.6.1 Key Person
11.6.2 Company overview
11.6.3 Recent Development
11.6.4 Product Portfolio
11.6.5 Sales Analysis
11.7 Medtronic
11.7.1 Key Person
11.7.2 Company overview
11.7.3 Recent Development
11.7.4 Product Portfolio
11.7.5 Sales Analysis
11.8 Volcano Corporation
11.8.1 Key Person
11.8.2 Company overview
11.8.3 Recent Development
11.8.4 Product Portfolio
11.8.5 Sales Analysis
Reach out to us
Call us on
USA: +1-678-302-0700
INDIA: +91-120-421-9822
Drop us an email at
info@renub.com